The Patent Finder

Ahr Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Ahr Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Ahr Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,238,645ITE for cancer intervention and eradication
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,195,182Ite for Cancer Intervention and Eradication
Formerly held
In force
 · Low confidence
In forceLow confidence
US 10,632,106Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,081,610Efficient and Scalable Synthesis of 2-(1'H-INDOLE-3'-Carbonyl)-THIAZOLE-4-Carboxylic Acid Methyl Ester and Its Structural Analogs
Formerly held
Lapsed on the fee record
Ended Sep 25, 2026 · High confidence
Lapsed on the fee recordEnded Sep 25, 2026High confidence
US 8,604,067ITE for cancer intervention and eradication
Formerly held
Lapsed on the fee record
Ended Dec 10, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 10, 2025USPTO record
US 9,694,000ITE for cancer intervention and eradication
Formerly held
Lapsed on the fee record
Ended Jul 4, 2025 · USPTO record
Lapsed on the fee recordEnded Jul 4, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited